Home ovulation test use and stress during subfertility evaluation: Subarm of a randomized controlled trial.
cortisol
infertility
ovulation tests
questionnaire
stress
timed intercourse
Journal
Women's health (London, England)
ISSN: 1745-5065
Titre abrégé: Womens Health (Lond)
Pays: United States
ID NLM: 101271249
Informations de publication
Date de publication:
Historique:
entrez:
30
3
2019
pubmed:
30
3
2019
medline:
30
1
2020
Statut:
ppublish
Résumé
A prospective, randomized controlled trial in women seeking to conceive examined the impact of using ovulation tests on self-reported levels of stress, psychological well-being, and quality of life in women with unexplained infertility. The test group used a home ovulation test to detect the day of ovulation, whereas the control group were provided with a predicted day of ovulation based on the average length of menstrual cycle reported during study recruitment. Volunteers collected their first morning urine samples to evaluate biochemical levels of stress (urinary cortisol and estrone-3-glucouronide) and completed questionnaires over two complete menstrual cycles. Overall, the use of digital ovulation tests by sub-fertile women under medical care had negligible negative effects and no detectable positive benefit on psychological well-being, according to multiple measurements of stress by questionnaire and biochemical markers. No significant differences were found between groups for all stress measures at the various study time points, except in relation to "couple concordance" where the test group scored much higher than the control group (mean difference at end of study was 21.25 (95% confidence interval: 9.25, 33.25; P = 0.0015)). The maximum difference in log cortisol: creatinine ratio between the test and control groups was -0.28 (95% confidence interval: -0.69, 0.13). These results do not support propositions that using digital ovulation tests can cause stress in women trying to conceive.
Identifiants
pubmed: 30924413
doi: 10.1177/1745506519838363
pmc: PMC6444416
doi:
Substances chimiques
estrone-3-glucuronide
2479-90-5
Estrone
2DI9HA706A
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1745506519838363Références
BMJ. 1990 Jan 27;300(6719):230-5
pubmed: 2106931
Front Med (Lausanne). 2018 Jan 09;4:250
pubmed: 29376054
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Fertil Steril. 1995 Oct;64(4):802-10
pubmed: 7672154
Hum Reprod. 2005 Sep;20(9):2542-5
pubmed: 15919775
NAACOGS Clin Issu Perinat Womens Health Nurs. 1992;3(2):335-42
pubmed: 1375835
Curr Med Res Opin. 2007 Feb;23(2):301-6
pubmed: 17288684
J Psychosom Obstet Gynaecol. 1993;14 Suppl:53-60
pubmed: 8142990
Fertil Steril. 1991 Jun;55(6):1137-43
pubmed: 2037107
Reprod Health. 2015 Dec 21;12:116
pubmed: 26689590
Womens Health (Lond). 2010 Jan;6(1):59-69
pubmed: 20088730
Hum Reprod. 2013 Jan;28(1):138-51
pubmed: 23081872
Aust Fam Physician. 2005 Mar;34(3):135-8
pubmed: 15799659
J Assist Reprod Genet. 2008 Feb-Mar;25(2-3):47-62
pubmed: 18274890
J Clin Psychiatry. 2011 Nov;72(11):e1563-9
pubmed: 22127200
MCN Am J Matern Child Nurs. 2014 Jan-Feb;39(1):35-40
pubmed: 24317142
Obstet Gynecol. 2002 Dec;100(6):1333-41
pubmed: 12468181
Contraception. 2006 Jan;73(1):65-71
pubmed: 16371298